Filter
293
Text search:
reagents
Featured
Recommendations
31
New Publications
70
Language
Document type
No document type
157
Guidelines
51
Studies & Reports
32
Strategic & Response Plan
25
Manuals
20
Fact sheets
3
Training Material
2
Situation Updates
2
Infographics
1
Countries / Regions
India
14
Western and Central Europe
10
Ethiopia
9
Malawi
9
Africa
9
Rwanda
8
Zimbabwe
7
Zambia
7
Kenya
7
Liberia
6
Uganda
6
Sierra Leone
5
Ghana
5
Eastern Europe
5
Global
5
Nigeria
4
Congo, Democratic Republic of
4
Syria
4
Tanzania
4
West and Central Africa
4
Latin America and the Carribbean
4
Cameroon
3
Bangladesh
3
Botswana
3
East and Southern Africa
3
Middle East and North Africa
3
Togo
2
Nepal
2
Iraq
2
Mozambique
2
Ukraine
2
Colombia
2
Venezuela
2
Guinea
1
Burkina Faso
1
Senegal
1
USA
1
Haiti
1
Philippines
1
Pakistan
1
Afghanistan
1
Lebanon
1
Chad
1
Cambodia
1
Indonesia
1
South Africa
1
Sudan
1
Benin
1
Namibia
1
Libya
1
Sri Lanka
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Asia
1
Fiji
1
Bhutan
1
Tajikistan
1
Iran
1
Turkmenistan
1
Japan
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
28
Pharmacy & Technologies
28
Key Resources
13
Public Health
11
Women & Child Health
2
Capacity Building
1
Toolboxes
TB
33
COVID-19
32
HIV
31
Rapid Response
16
NTDs
16
AMR
11
Pharmacy
10
2.0 Rapid Response
9
Ebola & Marburg
7
Cholera
5
Zika
5
Natural Hazards
4
Malaria
4
Polio
3
Conflict
3
Health Financing Toolbox
3
Caregiver
2
Planetary Health
2
Refugee
1
Mental Health
1
Specific Hazards
1
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec
...
Improve identification, verification, communication and coordination.
This guidance is intended to be one stop shop to improve the quality and effectiveness of health interventions in emergency, to respond to the most frequent scenarios and conditions.
The main document contains the most common elements to be found in emergencies. As much as possible they are one pag
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requiring improvements or sustained actions have been ide
...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
The objective of this guidance document is to support the public health professionals
in implementing effective surveillance of cholera in at-risk, endemic and epidemic
areas. This document has been developed by the Surveillance Working Group of the
Global Task Force for Cholera Control (GTFCC) a
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial
...
Assessment Report
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani
...
